PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapy.

Por Jianbiao Zhou, Chonglei Bi, Wee-Joo Chng, Lip-Lee Cheong, Shaw-Cheng Liu, Sylvia Mahara, Kian-Ghee Tay, Qi Zeng, Jie Li, Ke Guo, Cheng Peow Bobby Tan, Hanry Yu, Daniel H Albert, Chien-Shing Chen
Publicado em 2011-01-01